James R Bell Selected Research

James R Bell Research Topics

Disease

11	Ischemia 01/2016 - 03/2003
3	Cardiomegaly (Heart Hypertrophy) 06/2017 - 01/2013
3	Insulin Resistance 01/2017 - 06/2011
3	Opioid-Related Disorders (Opiate Addiction) 09/2009 - 07/2004
2	Cardiac Arrhythmias (Arrythmia) 12/2019 - 12/2011
2	Obesity 01/2019 - 10/2017
2	Heart Failure 06/2017 - 09/2013
2	Diabetic Cardiomyopathies 01/2017 - 09/2013
2	Reperfusion Injury 11/2015 - 11/2014
2	Infarction (Infarctions) 12/2013 - 09/2013
2	Cardiomyopathies (Cardiomyopathy) 01/2013 - 06/2011
1	Diabetes Complications 01/2017
1	Heart Diseases (Heart Disease) 01/2017
1	Contracture 11/2015
1	Myocardial Stunning (Stunned Myocardium) 11/2014
1	Heart Injuries 01/2014
1	Hypertrophy 09/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2013
1	Ventricular Tachycardia 08/2012
1	Rupture 08/2012
1	Fibrosis (Cirrhosis) 06/2011
1	Glucose Intolerance 06/2011
1	Hyperglycemia 06/2011
1	Opiate Overdose 09/2009
1	Alcoholism (Alcohol Abuse) 10/2006
1	Heroin Dependence (Heroin Abuse) 07/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 06/2017 - 01/2004
5	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 04/2015 - 08/2012
4	Estrogens (Estrogen)FDA Link 01/2019 - 09/2013
4	Aromatase (CYP19)IBA 10/2017 - 12/2011
3	SteroidsIBA 04/2015 - 09/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2013
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 11/2015 - 02/2015
2	SodiumIBA 11/2015 - 03/2003
2	Testosterone (Sustanon)FDA Link 05/2014 - 09/2013
2	Insulin (Novolin)FDA Link 01/2013 - 06/2011
2	FructoseIBA 01/2013 - 06/2011
2	Naltrexone (ReVia)FDA LinkGeneric 10/2006 - 07/2004
2	Adenosine Triphosphatases (ATPase)IBA 01/2004 - 03/2003
1	Pharmaceutical PreparationsIBA 12/2019
1	Hormones (Hormone)IBA 01/2019
1	Lipocalin-2IBA 06/2017
1	HexosaminesIBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2016
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 11/2015
1	HydrogenIBA 11/2015
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 11/2015
1	MineralocorticoidsIBA 11/2015
1	Phosphotransferases (Kinase)IBA 02/2015
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2014
1	ProdrugsIBA 12/2013
1	JNK Mitogen-Activated Protein KinasesIBA 12/2013
1	p38 Mitogen-Activated Protein KinasesIBA 12/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2013
1	KN 93IBA 08/2012
1	Buprenorphine (Subutex)FDA LinkGeneric 09/2009
1	Methadone (Dolophine)FDA LinkGeneric 09/2009
1	Opioid Analgesics (Opioids)IBA 08/2009
1	Naloxone Drug Combination Buprenorphine FDA Link 08/2009
1	Narcotic Antagonists (Opioid Antagonists)IBA 08/2009
1	Acamprosate (Campral)FDA Link 10/2006
1	DisulfidesIBA 10/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2004
1	S-Nitroso-N-AcetylpenicillamineIBA 10/2004
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2004
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2004
1	StaurosporineIBA 01/2004
1	EnzymesIBA 01/2004
1	phospholemmanIBA 01/2004
1	Protons (Proton)IBA 03/2003
1	Oxidants (Oxidizing Agents)IBA 03/2003

Therapy/Procedure

2	Therapeutics 12/2019 - 09/2013
2	Secondary Prevention 10/2006 - 07/2004